In preparation and expansion for the upcoming clinical trial, we have moved into a new office to house the clinical development staff.
One-carbon therapeutics AB management at ESMO to discuss the ODIN clinical phase 1/2 trial with potential clinical sites across Europe
One-carbon therapeutics AB is discussing the ODIN trial with several
